We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Determining Rupture Risk of Large Aneurysms

By HospiMedica staff writers
Posted on 24 Jun 2002
A new study showing that the diameter of an abdominal aortic aneurysm (AAA) is the best indicator of rupture risk may help doctors decide when it is safe to operate on high-risk AAA patients. More...
The study was reported in the June 12, 2002, issue of the Journal of the American Medical Association (JAMA).

Researchers observed 198 AAA patients and determined that the risk of rupture increases dramatically as the aneurysms develop beyond 5.5 cm in diameter. However, surgery for some patients may be a greater risk than the aneurysm. As aneurysms grow larger, they become more dangerous, so that surgery eventually becomes a lesser risk. Before this study, doctors could not accurately tell where the risk threshold was between operation and the aneurysm. Now, doctors can make a more accurate estimate of risk, based primarily on the size of the aneurysm.

The study was conducted by researchers at the US Veterans Affairs (VA) Medical Center in Minneapolis (MN, USA). An upcoming study will compare standard AAA repair with endovascular repair, a new method that repairs the AAA from inside the aorta through a small incision in the groin. Researchers hope to determine which method has the best long-term results.

"This study will also help elective-surgery patients make better-informed decisions,” said Frank Lederle, M.D., lead author. "Doctors can now give their patients specific figures depicting the risks of surgery based on the size of an aneurysm.”


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
MRI System
nanoScan MRI 3T/7T
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.